Cas no 1138156-77-0 (N-[4-[3-(3,4-Dihydroxyphenyl)prop-2-enoylamino]butyl]-3-(4-hydroxyphenyl)prop-2-enamide)
N-[4-[3-(3,4-Dihydroxyphenyl)prop-2-enoylamino]butyl]-3-(4-hydroxyphenyl)prop-2-enamide Chemical and Physical Properties
Names and Identifiers
-
- 3-(3,4-Dihydroxyphenyl)-N-(4-(3-(4-hydroxyphenyl)acrylamido)butyl)acrylamide
- (2E)-3-(3,4-Dihydroxyphenyl)-N-(4-{[(2E)-3-(4-hydroxyphenyl)-2-pr openoyl]amino}butyl)acrylamide
- N-p-coumaroyl-N'-caffeoylputrescine
- 3-(3,4-Dihydroxyphenyl)-N-[4-[[3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]amino]butyl]-2-propenamide
- [ "" ]
- (E)-N-[4-[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino]butyl]-3-(4-hydroxyphenyl)prop-2-enamide
- N-[4-[3-(3,4-Dihydroxyphenyl)prop-2-enoylamino]butyl]-3-(4-hydroxyphenyl)prop-2-enamide
- 1138156-77-0
- FS-10162
- 2-Propenamide, 3-(3,4-dihydroxyphenyl)-N-[4-[[3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]amino]butyl]-
- AKOS022184877
-
- MDL: MFCD20260951
- Inchi: 1S/C22H24N2O5/c25-18-8-3-16(4-9-18)6-11-21(28)23-13-1-2-14-24-22(29)12-7-17-5-10-19(26)20(27)15-17/h3-12,15,25-27H,1-2,13-14H2,(H,23,28)(H,24,29)/b11-6+,12-7+
- InChI Key: NDUQQMKMMARZRU-GNXRPPCSSA-N
- SMILES: O=C(/C=C/C1C=CC(=C(C=1)O)O)NCCCCNC(/C=C/C1C=CC(=CC=1)O)=O
Computed Properties
- Exact Mass: 396.169
- Monoisotopic Mass: 396.169
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 5
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 29
- Rotatable Bond Count: 9
- Complexity: 570
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 2
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.8
- Topological Polar Surface Area: 119
Experimental Properties
- Color/Form: Powder
- PSA: 118.89000
- LogP: 3.32440
N-[4-[3-(3,4-Dihydroxyphenyl)prop-2-enoylamino]butyl]-3-(4-hydroxyphenyl)prop-2-enamide Security Information
- Storage Condition:Store at room temperature, 2-8 ℃ is better
N-[4-[3-(3,4-Dihydroxyphenyl)prop-2-enoylamino]butyl]-3-(4-hydroxyphenyl)prop-2-enamide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A449042376-5mg |
N-p-Coumaroyl-N'-Caffeoylputrescine |
1138156-77-0 | 95% | 5mg |
$1057.88 | 2023-09-04 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN6024-5 mg |
N-p-Coumaroyl-N'-caffeoylputrescine |
1138156-77-0 | 5mg |
¥5365.00 | 2022-04-26 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | N72840-5 mg |
(2E)-3-(3,4-Dihydroxyphenyl)-N-(4-{[(2E)-3-(4-hydroxyphenyl)-2-pr openoyl]amino}butyl)acrylamide |
1138156-77-0 | 5mg |
¥5600.0 | 2021-09-08 | ||
| TargetMol Chemicals | TN6024-5 mg |
N-p-Coumaroyl-N'-caffeoylputrescine |
1138156-77-0 | 98% | 5mg |
¥ 7,200 | 2023-07-10 | |
| TargetMol Chemicals | TN6024-1 mL * 10 mM (in DMSO) |
N-p-Coumaroyl-N'-caffeoylputrescine |
1138156-77-0 | 98% | 1 mL * 10 mM (in DMSO) |
¥ 8900 | 2023-09-15 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN6024-5mg |
N-p-Coumaroyl-N'-caffeoylputrescine |
1138156-77-0 | 5mg |
¥ 7200 | 2023-09-07 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN6024-1 mL * 10 mM (in DMSO) |
N-p-Coumaroyl-N'-caffeoylputrescine |
1138156-77-0 | 1 mL * 10 mM (in DMSO) |
¥ 8900 | 2023-09-07 | ||
| TargetMol Chemicals | TN6024-5mg |
N-p-Coumaroyl-N'-caffeoylputrescine |
1138156-77-0 | 5mg |
¥ 7200 | 2024-07-19 | ||
| A2B Chem LLC | AA12466-5mg |
N-p-Coumaroyl-N'-Caffeoylputrescine |
1138156-77-0 | 95% | 5mg |
$3080.00 | 2024-01-04 | |
| Ambeed | A660395-5mg |
N-p-Coumaroyl-N'-Caffeoylputrescine |
1138156-77-0 | 98+% | 5mg |
$398.0 | 2024-04-26 |
N-[4-[3-(3,4-Dihydroxyphenyl)prop-2-enoylamino]butyl]-3-(4-hydroxyphenyl)prop-2-enamide Related Literature
-
Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
-
Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
-
Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
-
5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
Additional information on N-[4-[3-(3,4-Dihydroxyphenyl)prop-2-enoylamino]butyl]-3-(4-hydroxyphenyl)prop-2-enamide
Comprehensive Overview of N-[4-[3-(3,4-Dihydroxyphenyl)prop-2-enoylamino]butyl]-3-(4-hydroxyphenyl)prop-2-enamide (CAS No. 1138156-77-0)
The compound N-[4-[3-(3,4-Dihydroxyphenyl)prop-2-enoylamino]butyl]-3-(4-hydroxyphenyl)prop-2-enamide, with the CAS No. 1138156-77-0, is a bioactive molecule that has garnered significant attention in recent years due to its potential applications in pharmaceuticals and nutraceuticals. This dihydroxyphenyl-derived compound is structurally characterized by its prop-2-enamide backbone, which contributes to its unique biochemical properties. Researchers have explored its role as a potential antioxidant and anti-inflammatory agent, aligning with the growing consumer interest in natural health products.
One of the key structural features of this compound is the presence of 3,4-dihydroxyphenyl and 4-hydroxyphenyl groups, which are known to enhance its reactivity and biological activity. These functional groups are often associated with polyphenolic compounds, a class of molecules widely studied for their health benefits. The compound's CAS No. 1138156-77-0 serves as a unique identifier in chemical databases, facilitating its use in academic and industrial research. Recent studies have highlighted its potential in addressing oxidative stress-related conditions, a topic of high relevance in today's health-conscious society.
In the context of current trends, the demand for natural antioxidants and plant-derived bioactive compounds has surged, driven by increasing awareness of preventive healthcare. N-[4-[3-(3,4-Dihydroxyphenyl)prop-2-enoylamino]butyl]-3-(4-hydroxyphenyl)prop-2-enamide fits into this narrative, as its structure suggests potential synergies with other polyphenols like resveratrol and curcumin. These connections make it a compelling subject for further research, particularly in the development of functional foods and dietary supplements.
From a biochemical perspective, the compound's prop-2-enamide moiety is critical for its interaction with cellular targets. This feature has led to investigations into its potential role in modulating signaling pathways associated with inflammation and aging. Given the rising interest in anti-aging solutions and longevity science, this compound could emerge as a valuable candidate for future therapeutic development. Its CAS No. 1138156-77-0 ensures traceability in regulatory and safety assessments, which is essential for its adoption in consumer products.
The synthesis and characterization of N-[4-[3-(3,4-Dihydroxyphenyl)prop-2-enoylamino]butyl]-3-(4-hydroxyphenyl)prop-2-enamide involve advanced organic chemistry techniques, including HPLC purification and NMR spectroscopy. These methods are crucial for ensuring the compound's purity and efficacy, particularly when considering its potential use in nutraceutical formulations. As the global market for plant-based therapeutics expands, this compound's unique properties position it as a promising ingredient for innovative health solutions.
In conclusion, N-[4-[3-(3,4-Dihydroxyphenyl)prop-2-enoylamino]butyl]-3-(4-hydroxyphenyl)prop-2-enamide (CAS No. 1138156-77-0) represents a fascinating intersection of chemistry and biology. Its structural attributes and potential health benefits align with contemporary trends in preventive medicine and sustainable healthcare. Future research will likely explore its mechanisms of action and practical applications, solidifying its place in the evolving landscape of bioactive compounds.
1138156-77-0 (N-[4-[3-(3,4-Dihydroxyphenyl)prop-2-enoylamino]butyl]-3-(4-hydroxyphenyl)prop-2-enamide) Related Products
- 870640-22-5(2-Propenamide, N,N'-1,6-hexanediylbis[3-(3,4-dihydroxyphenyl)-)
- 1400-81-3(Caffeoylputrescine hydrochloride)
- 60422-23-3(2-Propenamide, N,N'-1,4-butanediylbis[3-(3,4-dihydroxyphenyl)-)
- 26148-06-1(Caffeoylputrescine)
- 29554-26-5(N-Caffeoylputrescine,(E)-)
- 101618-17-1(2,4-Pentadienamide, N-[4-(acetylamino)butyl]-5-(3,4-dihydroxyphenyl)-, (E,E)- (9CI))
- 101618-08-0(2-Propenamide, N,N'-1,4-butanediylbis[3-(3,4-dihydroxyphenyl)-, (E,E)-)
- 479244-15-0(2-Propenamide, 3-(3,4-dihydroxyphenyl)-N-propyl-, (2E)- (9CI))
- 870640-20-3(2-Propenamide, N,N'-1,3-propanediylbis[3-(3,4-dihydroxyphenyl)-)
- 870640-21-4(2-Propenamide, N,N'-1,5-pentanediylbis[3-(3,4-dihydroxyphenyl)-)